Neumora Therapeutics, Inc. · NASDAQ:NMRA
Kristina Burow reported a 20.70% stake in Neumora Therapeutics, Inc. (Schedule 13D/A)
Event Oct 27, 2025 · Filed Oct 29, 2025
Kristina Burow reported a 20.70% stake in Neumora Therapeutics, Inc., 33,958,967 shares, with active intent on Oct 27, 2025. Filed Oct 29, 2025 (Schedule 13D/A).
- Stake
- 20.70%
- Shares
- 33,958,967
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 18 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| ARCH Venture Fund VII, L.P. | 20.60% | 33,847,838 |
| ARCH Venture Fund VIII Overage, L.P. | 20.60% | 33,847,838 |
| ARCH Venture Fund X, L.P. | 20.60% | 33,847,838 |
| ARCH Venture Fund X Overage, L.P. | 20.60% | 33,847,838 |
| ARCH Venture Fund XII, L.P. | 20.60% | 33,847,838 |
| ARCH Venture Partners VII, L.P. | 20.60% | 33,847,838 |
| ARCH Venture Partners X, L.P. | 20.60% | 33,847,838 |
| ARCH Venture Partners X Overage, L.P. | 20.60% | 33,847,838 |
| ARCH Venture Partners XII, L.P. | 20.60% | 33,847,838 |
| ARCH Venture Partners VII, LLC | 20.60% | 33,847,838 |
| ARCH Venture Partners VIII, LLC | 20.60% | 33,847,838 |
| ARCH Venture Partners X, LLC | 20.60% | 33,847,838 |
| ARCH Venture Partners XII, LLC | 20.60% | 33,847,838 |
| Robert Nelsen | 20.60% | 33,847,838 |
| Keith Crandell | 20.60% | 33,847,838 |
| Clinton Bybee | 2.30% | 3,708,794 |
| Kristina Burow | 20.70% | 33,958,967 |
| Steven Gillis | 19.20% | 31,526,272 |
Source
Related
- Neumora Therapeutics, Inc.
- Burow Kristina
- Neumora Therapeutics, Inc. shareholders
- Schedule 13D/A · Burow Kristina · Apr 1, 2026
- Form 4 · Aurora Daljit Singh · Aug 21, 2026
- Form 4 · Aurora Daljit Singh · Aug 19, 2026
- Schedule 13G/A · K2 HealthVentures Equity Trust LLC · May 15, 2026
- Schedule 13G/A · Invus Public Equities, L.P. · May 4, 2026
- Schedule 13G · Invus Public Equities, L.P. · Feb 19, 2026